Your cart:$0.00(0 items) Check yourbonu$
Site search:
Categories list

Generic Metoprolol - Lopressor

Search by letter:ABCDEFGHIJKLMNOPQRSTUVWXYZ
Lopressor

Generic Lopressor

Metoprolol 25/50/100mg

Generic Lopressor is used for treating high blood pressure, long-term treatment of chest pain and reducing the risk of death because of heart problems in patients who have had a heart attack.

More info »
$0.69 Buy now!
Choose Your language:
Social bookmarks:
Testimonials
order has been received and I thank you for prompt delievery.......please keep in contact as I am sure there will be the need for more of these magic pills.........thank you.
Read more »

Our billing is certified by:

Secure shopping certificates


Special Offer!

Par Pharmaceutical Companies Reports First Quarter 2012 Results - MarketWatch (press release)
Updated NewsPar Pharmaceutical Companies Reports First Quarter 2012 ResultsMarketWatch (press release)Metoprolol: For the quarter ended March 31, 2012, net sales of metoprolol succinate were $61
Sun Pharma rating upped to overweight, target Rs. 670 - Financial Express
Sun Pharma rating upped to overweight, target Rs
Shoot Better Than Par With This Cheap Drug Stock - Forbes
Shoot Better Than Par With This Cheap Drug StockForbesSales of its biggest product, Metoprolol, which is the authorized generic for all strengths of AstraZeneca's Toprol XL, rose 9
Contrary to popular belief, beta-blockers don't prevent colorectal cancer - Los Angeles Times
Zee NewsContrary to popular belief, beta-blockers don't prevent colorectal cancerLos Angeles TimesAmong the best known are atenolol (Tenormin), bisoprolol (Zebeta), metoprolol (Lopresor or Toprol) and carvedilol (Coreg)
BP Meds No Help Against Colorectal Cancer - MedPage Today
BP Meds No Help Against Colorectal CancerMedPage TodayPrevious prescription drug database studies had also associated use of these drugs (which include metoprolol and atenolol) with a reduced risk of prostate, bladder, and all cancers combined
Centralux Ltd
bookmark Bookmark this site
Subscribe to the News